Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing ground-breaking solutions or leading collaborative research projects, our Funding Directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
If you’re looking for guidance on the types of funding you can access, innovation stages, or how to navigate the wider research landscape, we’ve created a dedicated set of resources to support you. On our Funding Support page, you can download toolkits that explain key terminology, study designs, and provide practical advice to strengthen your proposal. We also maintain an internal library of templates, such as Gantt charts, logic models, and risk registers, commonly required by funders.
Contact us at fundingsupport@lshubwales.com for guidance, bid review and editing, and help finding the perfect opportunity for your project.
Blavatnik Awards for young scientists in the United Kingdom in the categories of life sciences, physical sciences and engineering, and chemical sciences.
The funding bid supports the development of a Strategic Research and Innovation Agenda (SRIA) on cardiovascular diseases (CVDs) and related comorbidities in the EU. It aims to map existing research, identify gaps, integrate digital and personalised approaches, address sex-, gender-, and socio-demographic disparities, and guide prevention, early detection, and screening strategies through stakeholder engagement and evidence-based recommendations.
The funding bid supports research on the impact of digital technologies on the mental health of children and young adults. Projects should generate robust neurobiological and behavioral evidence, develop and test innovative digital interventions to promote responsible use, foster resilience, and prevent or mitigate mental disorders, incorporating sex-, gender-, and intersectional analyses, cohort or clinical studies, and end-user involvement.
The funding bid supports research on sex- and gender-specific cardiovascular disease (CVD) mechanisms to improve prevention, diagnosis, and treatment. It aims to develop tailored risk models, identify relevant determinants, exploit existing and new health data, and integrate social, cultural, and digital approaches, enhancing inclusive, innovative, and clinically impactful CVD interventions.
Funding to accelerate the translation of healthcare innovations tackling health inequalities and expand the entrepreneurial mindset of researchers and clinicians.
The aim of this fellowship is to support talented researchers who have completed a higher research degree and demonstrated career consolidation and productivity across previous appointments. The fellowship enables researchers to lead their own research programmes, establish an independent research niche, and begin building their own research teams. It represents a key first step-change towards research independence, supporting progression to future leadership roles. Applications are welcomed from across our remit to improve human health, spanning basic research into disease mechanisms through to translational and developmental clinical research, ensuring support for high-quality research with clear potential for impact.
This NIHR Public Health Research call invites proposals evaluating public mental health interventions to promote wellbeing or prevent mental ill-health in men. It emphasises a life‑course approach, targets health inequalities, encourages community‑level initiatives, and demands economic evaluation and involvement of people with lived experience.
This ongoing call seeks to fund high-quality research within specific gaps in the NIHR Public Health Research (PHR) portfolio. Commissioned calls against which NIHR has failed to fund sufficient research will remain open within this call in order to stimulate the required research activity.
This NIHR funding supports research into community-based interventions to improve veterans’ mental and physical health. It should address challenges of transition, stigma, and access through population-level approaches such as housing, employment, and coordinated care. Robust outcomes, economic evaluation, and stakeholder engagement are essential to inform policy and enhance holistic care.
Support for current NIHR Incubators and new groups that operate within NIHR's remit and address an area/discipline where there is a need to build research capacity on a national level.
Grant funding available to healthcare professionals in the UK for patient-focused applied research to improve treatment, care, and quality of life for leukaemia patients.
Funding available to young investigators at academic and cancer research institutions in Europe allowing them to undertake cancer research focusing on tumour heterogeneity.
Grants and fellowships available to researchers in the UK and US conducting research into the effects of digital technology usage on brain development, social behaviours and mental health in children and young people.
Sigma Theta Tau International Honour Society of Nursing - known as Sigma - is an international representative body for nurses and nursing. Its mission is to advance world health and celebrate nursing excellence in scholarship, leadership and service, and to respond to trends and issues in nursing and healthcare.
Funding is provided by Parkinson's UK through the Grants for Non-Drug Approaches scheme to support research into non-drug approaches that will play a vital part in helping people living with Parkinson's manage their daily challenges.
The funding bid supports research evaluating the clinical and cost-effectiveness of ambulation-focused rehabilitation programs for community-dwelling adults post-stroke with impaired walking. The study will assess impacts on quality of life, mental health, gait, mobility, independence, carer outcomes, and cost-effectiveness compared with usual care, considering demographic and regional variations.
Funding for independent scientific research in type 2 inflammation and its associated diseases, including atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyps.
Grants for researchers in Denmark to partner with international researchers to conduct exploratory research projects to develop tools to combat emerging and increasing threats from infectious diseases, including pathogenic fungi, novel antimicrobial resistance (AMR) tools and harnessing innate immunity.
Award for internationally acclaimed researchers in cancer care. The prize is awarded every two years to recognise outstanding contributions to translational cancer research and patient care.
Programme to support research projects relating to public health and social care in the UK that identify, evaluate and combine data from existing research studies to provide best evidence.
The Haleon Awards, together with the Oral & Dental Research Trust (ODRT), are small grant awards available to early career researchers to help fund research programmes into the fundamental mechanisms, prevention and management of plaque-related oral disease or tooth wear.
Funding to support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system in the UK.
Fellowship funding to enable researchers to visit centres for clinical or diagnostic virology in Europe, with the aim of furthering knowledge in clinical or diagnostic virology.
The Foundation's Conference Awards for Ageing Research support allied health professionals, nurses and pharmacists who are actively involved in ageing-related research and wish to disseminate their findings at national or international conferences. The aim is to support early career researchers who do not have access to conference funds through existing grants or fellowships.
Funding over a maximum of two years for innovative research examining the impact of environmental pollution and climate change on lung cancer risk, diagnosis and treatment, with the additional objective of delivering outcomes to inform innovative strategies to mitigate the effects of environmental pollution on lung cancer risk.
Accepting applications that will advance translational research to better understand the emergence, trajectory and outcomes of schizophrenia and related psychotic disorders in mid- to late-life, and to identify targets for future development of prevention and treatment interventions.
The NIAAA invites applications for research projects focused on closing the treatment gap for alcohol use disorder (AUD). Priorities include improving access, appeal, and implementation of treatments, analysing cost and insurance systems, and addressing health disparities. Projects may span multiple disciplines, with up to five years’ funding.
The National Cancer Institute (NCI) intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered may be used to probe cancer biology, to validate cancer targets or as the basis for optimised drugs.
This funding opportunity supports developing data and metadata standards for wearable technology to improve mental health research. Recipients will collaborate with manufacturers, researchers, and ethics experts to enable data integration, like DICOM for imaging. Funding depends on NIH budgets; projects may last up to four years with no budget cap.
Fellowship scheme for early career researchers and innovators looking to establish or transition to independence, or to develop their own ambitious plans within a commercial setting. Fellowships are available in any field of study covered by UK Research and Innovation.
Funding over a maximum of five years for translational research by UK research teams - including joint projects with teams in the US and Canada - based on developing a biological and mechanistic understanding of cancer aetiology, genesis and risk to develop precision prevention interventions.
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
Funding available to support early career researchers working in any discipline to prepare them to lead their own independent research programme and thereby benefit human life, health and wellbeing.
The funding bid supports research evaluating community-level initiatives that prevent or reduce loneliness in the UK. It seeks to assess the health and health inequality impacts of interventions—including community assets, place-based approaches, social skills programs, and virtual communities—focusing specifically on loneliness rather than social isolation, to inform effective population-level strategies.
Funding available to support academic researchers using AstraZeneca's compound library and screening robots to discover potential research starting points for small molecule medicinal drugs.
This funding supports research to develop and validate microbiome-based tools for early cancer prediction and prevention. It finances longitudinal data collection, AI-driven risk modelling, comparison with liquid biopsy tests, validation in independent cohorts, and stakeholder and citizen engagement to advance personalised, minimally invasive early detection aligned with the EU Cancer Mission.
The overall goal of this topic is to advance the understanding of older cancer patients' care needs, and develop innovative, age-sensitive care approaches and tools to boost overall quality of life.
The BAPRAS Pump Priming Fund offers a single grant each year to support pump priming clinical trial projects in the field of plastic surgery. The aim of the award is to support early feasibility work for a proposed clinical trial in support of a subsequent application for funding from the NIHR or other large funding body.
The Medical Research Council (MRC) provides experimental medicine grants to support academically-led experimental medicine projects that address gaps in current understanding of the causes, progression and treatment of human disease through experimental intervention, or challenge, in humans.
Sigma Theta Tau International Honour Society of Nursing - known as Sigma - is an international representative body for nurses and nursing. Its mission is to advance world health and celebrate nursing excellence in scholarship, leadership and service, and to respond to trends and issues in nursing and healthcare. In collaboration with the Rosemary Berkel Crisp Foundation, Sigma offers a Research Grant is to support nursing research in the critical areas of women's health, oncology and paediatrics.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
This funding supports implementation research to prevent, detect and manage chronic non-communicable diseases from early childhood to young adulthood. It finances evidence-based interventions in LMICs and underserved populations, addressing social determinants of health, equitable delivery, capacity building, and policy-relevant solutions to improve lifelong non-communicable disease outcomes.
The funding bid supports the development and clinical validation of improved point-of-care diagnostic devices. It aims to optimise accuracy, usability, and affordability, meet WHO REASSURED criteria, and demonstrate added value over existing tests, with priority for resource-limited settings and high-impact infectious or emergency disease applications.
Applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness and quality of digital mental health interventions that may impact mental health outcomes, including suicide behaviours and serious mental illness.
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders.
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. The overall goal of this NOFO is to identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans.
This funding opportunity supports clinical trials of orphan products (phases 1–3) for rare diseases with unmet medical needs. It aims to evaluate safety and/or efficacy to support new indications or labeling changes, ultimately increasing approved treatments and advancing innovative, collaborative approaches in rare disease drug development.
Capital grants for UK-registered private sector life sciences companies for large-scale R&D projects that are primarily capital investments and dependent on the grant to proceed.
